title: Omnicare forgot to mention ... Part D's effect not factored in its argument for hostile PharMerica takeover.
authors.forename: Jaimy
authors.initials: J
authors.lastname: Lee
mesh_terms: D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence / Q000592:standards; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006801:Humans; D054524:Medicare Part D / Q000191:economics* / Q000331:legislation & jurisprudence / Q000592:standards; D055553:Prescription Drugs / Q000191:economics / Q000600:supply & distribution; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence / Q000639:trends; D012866:Skilled Nursing Facilities / Q000191:economics* / Q000592:standards; D014481:United States; D014485:United States Federal Trade Commission / Q000331:legislation & jurisprudence
chemical_list: D055553:Prescription Drugs